Novus Biologicals

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Novus Biologicals
Public company
IndustryBiotech, Life sciences
Centennial, Colorado
ProductsAntibodies, kits, proteins, peptides, RNAi, inhibitors, ELISAs, slides and other research reagents

Novus Biologicals is a biotech company based in Centennial, Colorado. The company develops, licenses and markets research materials to scientists in academic, corporate and government laboratories. Novus began as a company focused on providing research-grade antibodies for the scientific market. It was acquired by Bio-Techne in 2014.


Founded in 1996, Novus Biologicals has developed more than 180,000 products,[1] ranging from antibodies to cell lysates and purification kits.[2]

In 2008, Novus became a limited liability company when Mainsail Partners invested in the company.[3] Novus Biologicals has reported double digit revenue growth every year since its inception, has been selected six years in a row to the Inc. (magazine) 5000 fastest-growing private companies in America,[4] and was on the 2009 list of Colorado Companies to Watch.[5]

In 2014, antibody and reagent supplier Bio-Techne, acquired Novus Biologicals for $60 million.[6] The acquisition was meant to provide scientists and doctors a broader selection of products in one location.


  1. ^ Business Week. Retrieved 23 November 2009.
  2. ^ Oredigger 5 October 2009.
  3. ^ Mainsail Partners. Retrieved 24 November 2009.
  4. ^ "Novus Biologicals Company Profile" Inc. (magazine) Retrieved 10 November 2009.
  5. ^ "50 Colorado companies: Fueling the economic fire" ColoradoBIZ Magazine. 1 June 2009.
  6. ^ "Bio-Techne Announces Agreement To Acquire Novus Biologicals". Bio-Techne (Press release). 2014-07-02. Retrieved 2015-04-25.

External links[edit]